Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgia Konstantinidou

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cancers|March 6, 2021
Targeted Therapies for Pancreatic Cancer: Overview of Current Treatments and New Opportunities for Personalized OncologyCédric Leroux, Georgia Konstantinidou
Frontiers in Oncology|May 12, 2020
Editorial: Oncogenic RAS-Dependent Reprogramming of Cellular PlasticityGeorgia Konstantinidou, Alessandro Rimessi
International Journal of Molecular Sciences|January 21, 2023
Lipid Metabolic Alterations in KRAS Mutant Tumors: Unmasking New Vulnerabilities for Cancer TherapyMaria Saliakoura, Georgia Konstantinidou
International Journal of Molecular Sciences|July 27, 2019
Targeting Long Chain Acyl-CoA Synthetases for Cancer TherapyMatteo Rossi Sebastiano, Georgia Konstantinidou
Journal of Experimental & Clinical Cancer Research : CR|January 9, 2022
Restriction of extracellular lipids renders pancreatic cancer dependent on autophagyMaria Saliakoura, Matteo Rossi Sebastiano, Ioanna Nikdima, et al.
EMBO Molecular Medicine|September 13, 2024
ERK5 suppression overcomes FAK inhibitor resistance in mutant KRAS-driven non-small cell lung cancerChiara Pozzato, Gonçalo Outeiro-Pinho, Mirco Galiè, et al.
Oncogene|February 9, 2020
The ACSL3-LPIAT1 signaling drives prostaglandin synthesis in non-small cell lung cancerMaria Saliakoura, Inés Reynoso-Moreno, Chiara Pozzato, et al.
EMBO Molecular Medicine|February 24, 2012
Translation-dependent mechanisms lead to PML upregulation and mediate oncogenic K-RAS-induced cellular senescencePier Paolo Scaglioni, Andrea Rabellino, Thomas M Yung, et al.
Science Advances|October 31, 2020
ACSL3-PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progressionMatteo Rossi Sebastiano, Chiara Pozzato, Maria Saliakoura, et al.
Cancer Research|October 1, 2009
Dual phosphoinositide 3-kinase/mammalian target of rapamycin blockade is an effective radiosensitizing strategy for the treatment of non-small cell lung cancer harboring K-RAS mutationsGeorgia Konstantinidou, Erik A Bey, Andrea Rabellino, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cancers|March 6, 2021
Targeted Therapies for Pancreatic Cancer: Overview of Current Treatments and New Opportunities for Personalized OncologyCédric Leroux, Georgia Konstantinidou
Frontiers in Oncology|May 12, 2020
Editorial: Oncogenic RAS-Dependent Reprogramming of Cellular PlasticityGeorgia Konstantinidou, Alessandro Rimessi
International Journal of Molecular Sciences|January 21, 2023
Lipid Metabolic Alterations in KRAS Mutant Tumors: Unmasking New Vulnerabilities for Cancer TherapyMaria Saliakoura, Georgia Konstantinidou
International Journal of Molecular Sciences|July 27, 2019
Targeting Long Chain Acyl-CoA Synthetases for Cancer TherapyMatteo Rossi Sebastiano, Georgia Konstantinidou
Journal of Experimental & Clinical Cancer Research : CR|January 9, 2022
Restriction of extracellular lipids renders pancreatic cancer dependent on autophagyMaria Saliakoura, Matteo Rossi Sebastiano, Ioanna Nikdima, et al.
EMBO Molecular Medicine|September 13, 2024
ERK5 suppression overcomes FAK inhibitor resistance in mutant KRAS-driven non-small cell lung cancerChiara Pozzato, Gonçalo Outeiro-Pinho, Mirco Galiè, et al.
Oncogene|February 9, 2020
The ACSL3-LPIAT1 signaling drives prostaglandin synthesis in non-small cell lung cancerMaria Saliakoura, Inés Reynoso-Moreno, Chiara Pozzato, et al.
EMBO Molecular Medicine|February 24, 2012
Translation-dependent mechanisms lead to PML upregulation and mediate oncogenic K-RAS-induced cellular senescencePier Paolo Scaglioni, Andrea Rabellino, Thomas M Yung, et al.
Science Advances|October 31, 2020
ACSL3-PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progressionMatteo Rossi Sebastiano, Chiara Pozzato, Maria Saliakoura, et al.
Cancer Research|October 1, 2009
Dual phosphoinositide 3-kinase/mammalian target of rapamycin blockade is an effective radiosensitizing strategy for the treatment of non-small cell lung cancer harboring K-RAS mutationsGeorgia Konstantinidou, Erik A Bey, Andrea Rabellino, et al.
Pageof 3